Neuralgic Amyotrophy

Description

Neuralgic amyotrophy (NA) is an uncommon disorder of the peripheral nervous system characterized by the sudden onset of extreme pain in the upper extremity followed by rapid multifocal motor weakness and atrophy and a slow recovery in months to years. NA includes both an idiopathic (INA, also known as Parsonage-Turner syndrome) and hereditary (HNA) form.

Clinical Features

Top most frequent phenotypes and symptoms related to Neuralgic Amyotrophy

  • Short stature
  • Muscle weakness
  • Cleft palate
  • Pain
  • Peripheral neuropathy
  • Skeletal muscle atrophy
  • Respiratory insufficiency
  • Narrow mouth
  • Arthralgia
  • Paralysis

And another 9 symptoms. If you need more information about this disease we can help you.

Click here to know more about Mendelian.

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
No data available about the known clinical features onset.

Alternative names

Neuralgic Amyotrophy Is also known as mononeuritis multiplex with brachial predilection, acute brachial plexus neuritis, immune brachial plexus neuropathy, brachial plexus neuritis, neuralgic shoulder amyotrophy.

Researches and researchers

Doctors, researchs, and experts related to Neuralgic Amyotrophy extracted from public data.

Neuralgic Amyotrophy Experts map



Current Researchs and researchers

  • ESPLUGUES DE LLOBREGAT — Pr Francesc PALAU

    Clinical geneticist - Genetic counsellor - Investigator of research project - Manager of biobank/collection - Coordinator of research network - Director of department

    • Institution/s:
      — Servicio de Neurología, Hospital Sant Joan de Déu Barcelona
      — Hospital Sant Joan de Déu Barcelona
      — Departamento de Genómica y Proteómica, Instituto de Biomedicina de Valencia (CSIC)
      — Servicio de Medicina Genética y Molecular, Hospital Sant Joan de Déu Barcelona
      — Hospital Sant Joan de Déu Barcelona
      — ISCIII - Instituto de Salud Carlos III
    • Research area/topic::

      BioMeder - Genes, proteins and signaling pathways in rare diseases


  • MADRID — Pr Francesc PALAU

    Clinical geneticist - Genetic counsellor - Investigator of research project - Manager of biobank/collection - Coordinator of research network - Director of department

    • Institution/s:
      — Servicio de Neurología, Hospital Sant Joan de Déu Barcelona
      — Hospital Sant Joan de Déu Barcelona
      — Departamento de Genómica y Proteómica, Instituto de Biomedicina de Valencia (CSIC)
      — Servicio de Medicina Genética y Molecular, Hospital Sant Joan de Déu Barcelona
      — Hospital Sant Joan de Déu Barcelona
      — ISCIII - Instituto de Salud Carlos III
    • Research area/topic::

      BioMeder - Genes, proteins and signaling pathways in rare diseases


  • VALENCIA — Pr Francesc PALAU

    Clinical geneticist - Genetic counsellor - Investigator of research project - Manager of biobank/collection - Coordinator of research network - Director of department

    • Institution/s:
      — Servicio de Neurología, Hospital Sant Joan de Déu Barcelona
      — Hospital Sant Joan de Déu Barcelona
      — Departamento de Genómica y Proteómica, Instituto de Biomedicina de Valencia (CSIC)
      — Servicio de Medicina Genética y Molecular, Hospital Sant Joan de Déu Barcelona
      — Hospital Sant Joan de Déu Barcelona
      — ISCIII - Instituto de Salud Carlos III
    • Research area/topic::

      BioMeder - Genes, proteins and signaling pathways in rare diseases


Neuralgic Amyotrophy Recommended genes panels

Panel Name, Specifity and genes Tested/covered
MitoMet®Plus aCGH Analysis.

By Baylor Miraca Genetics Laboratories (United States).

RGS9, RHO, GRK1, RLBP1, RNASEL, BCS1L, RP1, RP2, RP9, RPE65, RPGR, RPL35A, MRPL3, RPS14, RS1, SAG, SARDH, SCO2, SCP2, SDHB , (...)

View the complete list with 612 more genes
Specificity
1 %
Genes
100 %
Hereditary Neuralgic Amyotrophy.

By Baylor Miraca Genetics Laboratories (United States).

SEPT9
Specificity
100 %
Genes
100 %
SEPT9 Deletion/Duplication Analysis.

By Baylor Miraca Genetics Laboratories (United States).

SEPT9
Specificity
100 %
Genes
100 %
SEPT9 DNA Sequencing Test.

By Athena Diagnostics Inc (United States).

SEPT9
Specificity
100 %
Genes
100 %
Charcot-Marie-Tooth.

By Human Genetics University Hospital Bern (Switzerland).

YARS, PRX, BSCL2, GDAP1, LITAF, FIG4, FGD4, SBF2, CTDP1, SH3TC2, DNM2, EGR2, GARS, GJB1, MPZ, SEPT9, MTMR2, NDRG1, NEFL, PDK3 , (...)

View the complete list with 2 more genes
Specificity
5 %
Genes
100 %
SEPT9. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).

SEPT9
Specificity
100 %
Genes
100 %
SEPT9. MLPA testing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).

SEPT9
Specificity
100 %
Genes
100 %
Amyotrophy hereditary neuralgic (sequence analysis of SEPT9 gene).

By CGC Genetics (Portugal).

SEPT9
Specificity
100 %
Genes
100 %

You can get up to 23 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

ORPHANET Genetic Syndrome Finder

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like STRIATONIGRAL DEGENERATION, INFANTILE; SNDI MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MODY2